ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in real-world settings: rationale and design-Reference-Cited by-同舟云学术

ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in real-world settings: rationale and design

Published:2021-10-12 Issue:3 Volume:74 Page:530-537
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Fulcher Gregory R.^ORCID,Jarlov Henrik,Piltoft Johanne Spanggaard,Singh Kiran Pal,Liu Lei,Mohamed Mafauzy,Nicodemus Nemencio Almare,Al-Jaser Saleh Jaser,Kok Adri

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12020-021-02887-8.pdf

Reference21 articles.

1. V.A. Fonseca, Defining and characterizing the progression of type 2 diabetes. Diabetes Care 32, S151–S156 (2009)

2. S.E. Inzucchi, R.M. Bergenstal, J.B. Buse, M. Diamant, E. Ferrannini, M. Nauck, A.L. Peters, A. Tsapas, R. Wender, D.R. Matthews, Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38, 140–149 (2015)

3. K. Khunti, D. Millar-Jones, Clinical inertia to insulin initiation and intensification in the UK: a focused literature review. Prim Care Diabetes 11, 3–12 (2017)

4. R.R. Holman, A.J. Farmer, M.J. Davies, J.C. Levy, J.L. Darbyshire, J.F. Keenan, S.K. Paul, Three-year efficacy of complex insulin regimens in type 2 diabetes. N. Engl. J. Med. 361, 1736–1747 (2009)

5. G. Grunberger, D. Sze, A. Ermakova, R. Sieradzan, T. Oliveria, E.M. Miller, Treatment intensification with insulin pumps and other technologies in patients with type 2 diabetes: results of a physician survey in the United States. Clin. Diabetes 38, 47–55 (2020)

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initiation or switch to insulin degludec/insulin aspart in adults with type 2 diabetes in India: Results from a prospective, non-interventional, real-world study;Journal of Family Medicine and Primary Care;2024-09

2. Initiating or switching to insulin degludec/insulin aspart in a real‐world population of adults with type 2 diabetes in Australia: results from a prospective, non‐interventional study;Internal Medicine Journal;2024-08-22

3. Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults With Type 2 Diabetes in the Philippines;Journal of the ASEAN Federation of Endocrine Societies;2024-08-04

4. Improvement in Glycemic Indices and Point in Range by Addition or Switch to IDegAsp–Real-World Evidence;Journal of Diabetology;2024-07

5. Initiating or switching to IDegAsp in a real-world South African population with type 2 diabetes – a cohort analysis from the ARISE study;Journal of Endocrinology, Metabolism and Diabetes of South Africa;2023-05-19